New Studies Evaluate Cannabis Treatment in Epilepsy Patients

Warning message

The subscription service is currently unavailable. Please try again later.

Studies presented at the American Epilepsy Society’s (AES) 68th Annual Meeting offer new insights into diverse patients’ experience with cannabidiol (CBD) for treatment of patients with various forms of epilepsy.

Although there have been many anecdotal reports regarding cannabis and its derivative CBD in the treatment of people with epilepsy, especially in very young children who severe forms of epilepsy, such as Lennox Gastaut Syndrome (LGS) or Dravet Syndrome (DS), there is little scientific evidence regarding its efficacy in this patient population. At the AES Annual Meeting, three new studies focused on the use of cannabis in epilepsy were featured to offer new insights.

The first of three studies is from Colorado, where marijuana is legal for both medical and recreational use. The physicians and researchers at Children’s Hospital Colorado and the University of Colorado have a unique perspective on CBD, due to the large number of cases they have...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.